Hemothorax and retroperitoneal hematoma after anticoagulation with enoxaparin

Southern Medical Journal

Volumn 95, Issue 8, 2002, Pages 936-938

  Mrug, Michal ^a   Mishra, Prashant V ^a   Lusane, Henry C ^a   Cunningham, J Martin ^a   Alpert, Martin A ^a  

^a UNIVERSITY OF SOUTH ALABAMA MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBIOTIC AGENT; ANTICOAGULANT AGENT; AZITHROMYCIN; CEFTRIAXONE; CORTICOSTEROID; ENOXAPARIN; IPRATROPIUM BROMIDE; LEVALBUTEROL; LOW MOLECULAR WEIGHT HEPARIN; METHYLPREDNISOLONE SODIUM SUCCINATE; SALBUTAMOL; TIMENTIN; ZANAMIVIR;

ADULT; ANTICOAGULANT THERAPY; ARTICLE; CASE REPORT; CHRONIC OBSTRUCTIVE LUNG DISEASE; COMPUTER ASSISTED TOMOGRAPHY; DRUG INDUCED DISEASE; FEMALE; HEMATOTHORAX; HUMAN; LUNG EMBOLISM; PNEUMONIA; RETROPERITONEAL HEMATOMA; THORACOCENTESIS; THROMBOEMBOLISM; TREATMENT OUTCOME;

EID: 0036337566     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/00007611-200208000-00031     Document Type: Article

References (12)

1. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage?
2. Life-threatening retroperitoneal hematoma caused by anticoagulant therapy for myocardial infarction after SWL
3. Treatment of acute venous thromboembolism with low molecular weight heparin (Fragmin). Results of a double-blind randomized study
4. Retroperitoneal hematoma and enoxaparin
5. Enoxaparin prevents death and cardiac ischemic events in unstable angina/non-Q-wave myocardial infarction. Results of the Thrombolysis in Myocardial Infarction (TIMI) 11B Trial
6. Hemothorax and retro-peritoneal hematoma with the secondary posthemorrhagic anemia as a complication of oral anticoagulant and non-steroidal anti-inflammatory drug therapy
7. Multifocal bleeding due to anticoagulant therapy
8. Hemothorax complicating anticoagulation for pulmonary embolus. A report of 2 patients
9. A comparison of low-molecular-weight heparin with. Unfractionated heparin for unstable coronary artery disease
10. Enoxaparin. A reappraisal of its pharmacology and clinical applications in the prevention and treatment of thromboembolic disease
11. Dose-ranging trial of enoxaparin for unstable angina: Results of TIMI IIA
12. Hemorrhagic complications of anticoagulant treatment